(Q36268379)

English

A retrospective, comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin, levofloxacin, ciprofloxacin, or ceftriaxone

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

A retrospective, comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin, levofloxacin, ciprofloxacin, or ceftriaxone (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

hospitalization

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Pablo C Okhuysen

0 references

author name string

John F Mohr

1

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

Peggy S McKinnon

2

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

Patti J Peymann

3

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

Irene Kenton

4

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

Edward Septimus

5

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

Pablo C Okhuysen

6

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

language of work or name

0 references

publication date

1 October 2005

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

1303-1309

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

Acute hyperglycemic crisis in the elderly.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1303

21 January 2018

Relationship of baseline glucose homeostasis to hyperglycemia during medical critical illness

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1303

21 January 2018

Hypoglycemia as a predictor of mortality in hospitalized elderly patients

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1303

21 January 2018

Effects of fluoroquinolones on insulin secretion and beta-cell ATP-sensitive K+ channels.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1303

21 January 2018

Effects of lomefloxacin and norfloxacin on pancreatic beta-cell ATP-sensitive K(+) channels

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1303

21 January 2018

Gatifloxacin and the elderly: pharmacokinetic-pharmacodynamic rationale for a potential age-related dose reduction

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1303

21 January 2018

Refractory hypoglycemia from ciprofloxacin and glyburide interaction

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1303

21 January 2018

Glyburide-ciprofloxacin interaction with resistant hypoglycemia

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1303

21 January 2018

Possible gatifloxacin-induced hyperglycemia

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1303

21 January 2018

Severe and resistant hypoglycemia associated with concomitant gatifloxacin and glyburide therapy

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1303

21 January 2018

Gatifloxacin-induced hyperglycemia

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1303

21 January 2018

Severe and persistent hypoglycemia due to gatifloxacin interaction with oral hypoglycemic agents

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1303

21 January 2018

Possible gatifloxacin-induced hypoglycemia

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1303

21 January 2018

Fatal hypoglycemia associated with levofloxacin

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1303

21 January 2018

Replication of the Weber effect using postmarketing adverse event reports voluntarily submitted to the United States Food and Drug Administration

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1303

21 January 2018

A dose-escalation study of the safety, tolerability, and pharmacokinetics of intravenous gatifloxacin in healthy adult men.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1303

21 January 2018

Effect of multiple-dose gatifloxacin or ciprofloxacin on glucose homeostasis and insulin production in patients with noninsulin-dependent diabetes mellitus maintained with diet and exercise.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.2005.25.10.1303

21 January 2018

Identifiers

10.1592/PHCO.2005.25.10.1303

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36268379&oldid=1622684362"